$KTTA

$0.40 -$0.00 (0.65%) Close

$KTTA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 33.4M shares outstanding

Who owns KTTA?

By type of holder

Institutions 50.2% Insiders 12.6% Everyone else 37.2%

Concentration Top 10 holders own 58.5%

Coastlands Capital LP 11.5% · Cable Car Capital, LP 9.0%

Institutional ownership

50.2%

+11.9 pts vs last qtr

Institutional holders

+4 vs last qtr

Net shares bought

+4.0M

by institutions in Q2 2026

New / sold out

5 / 1

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Jupiter Topco LLC NEW +2.1M
Opaleye Management Inc. NEW +2.1M

Biggest sellers in Q2 2026

Janus Henderson Group PLC SOLD OUT −2.1M
Vivo Capital, LLC −1.6M

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Pasithea Therapeutics Corp in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2025

+541.5%

+541.47% a year

Each share's claim on the business

−84.4%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $1.07M

over 2 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years7% Under 1 year93%

Quarterly turnover

53.6%

of institutional shares changed hands

Top 10 managers, median time held

2 quarters

Super Investors

Investment managers reporting KTTA on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
CC Cable Car Capital, LP	3.0M	8.98%	+1.8M (+148.7%)	Q4 '25	0.0%
Shares held by quarter Peak holding3.0M (Q2'26) Change over 8 quarters+3.0M Share of the company8.980% Cable Car Capital, LP's full portfolio →
SC Stonepine Capital Management, LLC	2.2M	6.59%	+1.4M (+164.8%)	Q4 '25	0.6%
Shares held by quarter Peak holding2.2M (Q2'26) Change over 8 quarters+2.2M Share of the company6.590% Stonepine Capital Management, LLC's full portfolio →

Cable Car Capital, LP

3.0M

% of company

8.98%

Change vs last qtr

+1.8M (+148.7%)

Held since

Q4 '25

Stonepine Capital Management, LLC

2.2M

% of company

6.59%

Change vs last qtr

+1.4M (+164.8%)

Held since

Q4 '25

24 more super investors behind a free account

See every manager holding Pasithea Therapeutics Corp, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting KTTA on Form N-PORT; together they hold 3.4% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
AP AdvisorShares Psychedelics ETF AdvisorShares Trust	$483K	937.6K	2.81%	1.09%	June 30, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$65.1K	126.3K	0.38%	0.00%	June 30, 2026

AdvisorShares Psychedelics ETF

AdvisorShares Trust

Position value

$483K

% of company

2.81%

% of the fund

1.09%

As of

June 30, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$65.1K

% of company

0.38%

% of the fund

0.00%

As of

June 30, 2026

3 more funds behind a free account

See every fund holding Pasithea Therapeutics Corp and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
CC Coastlands Capital LP Insider	3.8M	11.48%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company11.480% Coastlands Capital LP's insider activity →
LS Lawrence Steinman 5%+ holder 13D · 3.1%	83.9K	0.25%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company0.250% Disclosed stake13D · 3.1% View the 13D/G filing →

Coastlands Capital LP

Insider

3.8M

% of company

11.48%

Change vs last qtr

—

Held since

—

Lawrence Steinman

5%+ holder13D · 3.1%

83.9K

% of company

0.25%

Change vs last qtr

—

Held since

—

4 more holders behind a free account

See every insider and 5%+ holder of Pasithea Therapeutics Corp.

Comments